Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
about
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinomaHigh toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer.
P2860
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
@en
type
label
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
@en
prefLabel
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
@en
P2093
P50
P1476
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
@en
P2093
Alessandro Bittoni
Francesco Cellini
Ivana Cataldo
Michele Reni
Nicola Silvestris
Vincenzo Valentini
Vito Longo
Vito Lorusso
P304
P356
10.1016/J.CRITREVONC.2015.11.016
P50
P577
2015-11-23T00:00:00Z